Literature DB >> 17904184

Subcellular localization of hepatitis E virus (HEV) replicase.

Shagufta Rehman1, Neeraj Kapur, Hemlata Durgapal, Subrat Kumar Panda.   

Abstract

Hepatitis E virus (HEV) is a hepatotropic virus with a single sense-strand RNA genome of approximately 7.2 kb in length. Details of the intracellular site of HEV replication can pave further understanding of HEV biology. In-frame fusion construct of functionally active replicase-enhanced green fluorescent protein (EGFP) gene was made in eukaryotic expression vector. The functionality of replicase-EGFP fusion protein was established by its ability to synthesize negative-strand viral RNA in vivo, by strand-specific anchored RT-PCR and molecular beacon binding. Subcellular co-localization was carried out using organelle specific fluorophores and by immuno-electron microscopy. Fluorescence Resonance Energy Transfer (FRET) demonstrated the interaction of this protein with the 3' end of HEV genome. The results show localization of replicase on the endoplasmic reticulum membranes. The protein regions responsible for membrane localization was predicted and identified by use of deletion mutants. Endoplasmic reticulum was identified as the site of replicase localization and possible site of replication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17904184     DOI: 10.1016/j.virol.2007.07.036

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  27 in total

1.  Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.

Authors:  Nereida Jiménez de Oya; Estela Escribano-Romero; Ana-Belén Blázquez; María Lorenzo; Miguel A Martín-Acebes; Rafael Blasco; Juan-Carlos Saiz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 2.  Hepatitis e: molecular virology and pathogenesis.

Authors:  Subrat K Panda; Satya P K Varma
Journal:  J Clin Exp Hepatol       Date:  2013-05-30

Review 3.  Hepatitis E Virus Genome Structure and Replication Strategy.

Authors:  Scott P Kenney; Xiang-Jin Meng
Journal:  Cold Spring Harb Perspect Med       Date:  2019-01-02       Impact factor: 6.915

Review 4.  Therapeutic targets for the treatment of hepatitis E virus infection.

Authors:  Scott P Kenney; Xiang-Jin Meng
Journal:  Expert Opin Ther Targets       Date:  2015-06-13       Impact factor: 6.902

Review 5.  Zoonotic hepatitis E: animal reservoirs and emerging risks.

Authors:  Nicole Pavio; Xiang-Jin Meng; Christophe Renou
Journal:  Vet Res       Date:  2010-04-02       Impact factor: 3.683

6.  NTPase and 5' to 3' RNA duplex-unwinding activities of the hepatitis E virus helicase domain.

Authors:  Yogesh A Karpe; Kavita S Lole
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

7.  Rescue of a genotype 4 human hepatitis E virus from cloned cDNA and characterization of intergenotypic chimeric viruses in cultured human liver cells and in pigs.

Authors:  Laura Córdoba; Alicia R Feagins; Tanja Opriessnig; Caitlin M Cossaboom; Barbara A Dryman; Yao-Wei Huang; Xiang-Jin Meng
Journal:  J Gen Virol       Date:  2012-07-25       Impact factor: 3.891

Review 8.  Molecular biology and replication of hepatitis E virus.

Authors:  Dianjun Cao; Xiang-Jin Meng
Journal:  Emerg Microbes Infect       Date:  2012-08-22       Impact factor: 7.163

9.  Lack of processing of the expressed ORF1 gene product of hepatitis E virus.

Authors:  Suganthi Suppiah; Yumei Zhou; Teryl K Frey
Journal:  Virol J       Date:  2011-05-20       Impact factor: 4.099

10.  Analysis of antiviral response in human epithelial cells infected with hepatitis E virus.

Authors:  Pradip B Devhare; Subhashis N Chatterjee; Vidya A Arankalle; Kavita S Lole
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.